Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Patent 10238749 was granted and assigned to Alnylam Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128031 Method of improving psychosocial health
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+292 characters)
Article

Patent abstract

The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the angiotensinogen (AGT) gene, and methods of using such RNAi agents to inhibit expression of AGT and methods of treating subjects having an AGT-associated disorder, e.g., hypertension.

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834661 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
Edits on 6 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Current Assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102387490
Date of Patent
March 26, 2019
0
Patent Application Number
153131450
Date Filed
May 22, 2015
0
Patent Citations Received
‌
US Patent 10814007 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
‌
US Patent 11015201 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
‌
US Patent 11040057 Pharmaceutical compositions and methods for potentiating gene silencing
0
‌
US Patent 11419942 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
‌
US Patent 11491142 Compositions and methods for treating neuropsychiatric disorders
0
‌
US Patent 11583520 Compositions and methods for treating neuropsychiatric disorders
0
Patent Primary Examiner
‌
Terra C Gibbs
0
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
Edits on 22 Feb, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11583520 Compositions and methods for treating neuropsychiatric disorders
0
Edits on 9 Nov, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11491142 Compositions and methods for treating neuropsychiatric disorders
0
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 24 Aug, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11419942 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11040057 Pharmaceutical compositions and methods for potentiating gene silencing
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11015201 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Edits on 7 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10814007 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Edits on 25 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 25 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Infobox
Is a
Patent
Patent
Patent applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Current assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10238749
Date of patent
March 26, 2019
Patent application number
15313145
Date Filed
May 22, 2015
Patent primary examiner
‌
Terra C Gibbs

Find more entities like US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.